⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Pomerantz LLP Advises Shareholders of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
December 15, 2025 Deadline: Join Class Action Lawsuit Against MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) Investors - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MLTX To Contact Him Directly To Discuss Their Options
prnewswire.com
MLTX
MLTX CLASS ACTION NOTICE: Berger Montague Encourages MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action
prnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics(MLTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
prnewswire.com
MLTX
Pomerantz LLP Advises of Securities Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX